Literature DB >> 11023795

Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).

A J Powell1, J A Read, M J Banfield, F Gunn-Moore, S D Yan, J Lustbader, A R Stern, D M Stern, R L Brady.   

Abstract

Human type II hydroxyacyl-CoA dehydrogenase/amyloid-beta binding alcohol dehydrogenase (HADH II/ABAD) is an oxidoreductase whose salient features include broad substrate specificity, encompassing 3-hydroxyacyl-CoA derivatives, hydroxysteroids, alcohols and beta-hydroxybutyrate, and the capacity to bind amyloid-beta peptide, leading to propagation of amyloid-induced cell stress. In this study, we examine the structure and enzymatic activity of the homologous rat HADH II/ABAD enzyme. We report the crystal structure of rat HADH II/ABAD as a binary complex with its NADH cofactor to 2.0 A resolution, as a ternary complex with NAD(+) and 3-ketobutyrate (acetoacetate) to 1.4 A resolution, and as a ternary complex with NADH and 17 beta-estradiol to 1.7 A resolution. This first crystal structure of an HADH II confirms these enzymes are closely related to the short-chain hydroxysteroid dehydrogenases and differ substantially from the classic, type I 3-hydroxyacyl-CoA dehydrogenases. Binding of the ketobutyrate substrate is accompanied by closure of the active site specificity loop, whereas the steroid substrate does not appear to require closure for binding. Despite the different chemical nature of the two bound substrates, the presentation of chemical groups within the active site of each complex is remarkably similar, allowing a general mechanism for catalytic activity to be proposed. There is a characteristic extension to the active site that is likely to accommodate the CoA moiety of 3-hydroxyacyl-CoA substrates. Rat HADH II/ABAD also binds amyloid-beta (1-40) peptide with a K(D) of 21 nM, which is similar to the interaction exhibited between this peptide and human HADH II/ABAD. These studies provide the first structural insights into HADH II/ABAD interaction with its substrates, and indicate the relevance of the rodent enzyme and associated rodent models for analysis of HADH II/ABAD's physiologic and pathophysiologic properties. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023795     DOI: 10.1006/jmbi.2000.4139

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  Substrate recognition by the human fatty-acid synthase.

Authors:  Loretha Carlisle-Moore; Chris R Gordon; Carl A Machutta; W Todd Miller; Peter J Tonge
Journal:  J Biol Chem       Date:  2005-10-07       Impact factor: 5.157

Review 2.  Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?

Authors:  Eva Borger; Laura Aitken; Heng Du; Wenshen Zhang; Frank J Gunn-Moore; Shirley Shi Du Yan
Journal:  Curr Alzheimer Res       Date:  2013-01       Impact factor: 3.498

3.  Crystal structure of AibC, a reductase involved in alternative de novo isovaleryl coenzyme A biosynthesis in Myxococcus xanthus.

Authors:  Tobias Bock; Rolf Müller; Wulf Blankenfeldt
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-07-29       Impact factor: 1.056

4.  Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry.

Authors:  Desiree H Fong; Albert M Berghuis
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

Review 5.  Virtual screening applications in short-chain dehydrogenase/reductase research.

Authors:  Katharina R Beck; Teresa Kaserer; Daniela Schuster; Alex Odermatt
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-09       Impact factor: 4.292

Review 6.  HSD10 disease: clinical consequences of mutations in the HSD17B10 gene.

Authors:  Johannes Zschocke
Journal:  J Inherit Metab Dis       Date:  2011-11-30       Impact factor: 4.982

7.  Lysophosphatidylethanolamine is a substrate for the short-chain alcohol dehydrogenase SocA from Myxococcus xanthus.

Authors:  Madhavi Avadhani; Roland Geyer; David C White; Lawrence J Shimkets
Journal:  J Bacteriol       Date:  2006-10-06       Impact factor: 3.490

8.  High substrate specificity of ipsdienol dehydrogenase (IDOLDH), a short-chain dehydrogenase from Ips pini bark beetles.

Authors:  Rubi Figueroa-Teran; Heidi Pak; Gary J Blomquist; Claus Tittiger
Journal:  J Biochem       Date:  2016-03-06       Impact factor: 3.387

9.  A novel HSD17B10 mutation impairing the activities of the mitochondrial RNase P complex causes X-linked intractable epilepsy and neurodevelopmental regression.

Authors:  Marni J Falk; Xiaowu Gai; Megumi Shigematsu; Elisa Vilardo; Ryuichi Takase; Elizabeth McCormick; Thomas Christian; Emily Place; Eric A Pierce; Mark Consugar; Howard B Gamper; Walter Rossmanith; Ya-Ming Hou
Journal:  RNA Biol       Date:  2016-03-07       Impact factor: 4.652

10.  Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD.

Authors:  Naeem Shafqat; Hanns-Ulrich Marschall; Charlotta Filling; Erik Nordling; Xiao-Qiu Wu; Lars Björk; Johan Thyberg; Eva Mårtensson; Samina Salim; Hans Jörnvall; Udo Oppermann
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.